Award
NIH Reporter #RFA-CA-23-029
Immune determinants modulating cancer development in Lynch Syndrome
Recipient
Not Specified
Award Amount
$818,489.00
Ceiling
$818,489.00
Awarded
July 15, 2026
Identifier
RFA-CA-23-029
Award for research on immune factors affecting cancer development in Lynch Syndrome to develop prevention strategies.
Description
This project aims to investigate immune determinants that influence cancer progression in Lynch Syndrome, focusing on neoantigen expression, T cell responses, and immune microenvironment features for prevention strategies.